Thioesterase PPT1 balances viral resistance and efficient T cell crosspriming in dendritic cells

J Exp Med. 2019 Sep 2;216(9):2091-2112. doi: 10.1084/jem.20190041. Epub 2019 Jul 1.

Abstract

Conventional type 1 dendritic cells (cDC1s) are inherently resistant to many viruses but, paradoxically, possess fewer acidic phagosomes that enable antigen retention and cross-presentation. We report that palmitoyl-protein thioesterase 1 (PPT1), which catabolizes lipid-modified proteins in neurons, is highly expressed in cDC1s. PPT1-deficient DCs are more susceptible to vesicular stomatitis virus (VSV) infection, and mice with PPT1 deficiency in cDC1s show impaired response to VSV. Conversely, PPT1-deficient cDC1s enhance the priming of naive CD8+ T cells into tissue-resident KLRG1+ effectors and memory T cells, resulting in rapid clearance of tumors and Listeria monocytogenes Mechanistically, PPT1 protects steady state DCs from viruses by promoting antigen degradation and endosomal acidification via V-ATPase recruitment. After DC activation, immediate down-regulation of PPT1 is likely to facilitate efficient cross-presentation, production of costimulatory molecules and inflammatory cytokines. Thus, PPT1 acts as a molecular rheostat that allows cDC1s to crossprime efficiently without compromising viral resistance. These results suggest potential therapeutics to enhance cDC1-dependent crosspriming.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acids / metabolism
  • Animals
  • Antigens / immunology
  • Cross-Priming / immunology*
  • Dendritic Cells / immunology*
  • Disease Resistance*
  • Immunity
  • Listeria monocytogenes
  • Mice, Knockout
  • Phagosomes / metabolism
  • T-Lymphocytes / immunology*
  • Thiolester Hydrolases / metabolism*
  • Vesicular Stomatitis / immunology*
  • Vesicular Stomatitis / virology*
  • Vesiculovirus / immunology*

Substances

  • Acids
  • Antigens
  • Thiolester Hydrolases
  • palmitoyl-protein thioesterase